Excessive Neutropenia for Weekly Everolimus + Docetaxel Doctors Lounge For patients with metastatic breast cancer, weekly treatment with everolimus plus docetaxel every three weeks results in dose-limiting neutropenia and variable clearance of both drugs, according to a phase 1 study published in the May 1 issue of Cancer ... |
